Eldecalcitol Add-On to Risedronate Reduces Bone Loss from Aromatase Inhibitors in Postmenopausal Breast Cancer Patients.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM(2025)
Key words
aromatase inhibitor-associated bone loss,AIBL,early-stage breast cancer,EBC,eldecalcitol,risedronate,trabecular bone score,TBS
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined